# Assessing the Efficacy and Safety of DEXTENZA in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal Detachment

> **NCT04464629** · PHASE4 · TERMINATED · sponsor: **Midwest Eye Institute** · enrollment: 7 (actual)

## Conditions studied

- Retinal Detachment

## Interventions

- **DRUG:** Dextenza
- **DRUG:** Prednisolone Acetate

## Key facts

- **NCT ID:** NCT04464629
- **Lead sponsor:** Midwest Eye Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-14
- **Primary completion:** 2023-01-25
- **Final completion:** 2023-01-25
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Poor enrollment
- **Last updated:** 2023-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04464629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04464629, "Assessing the Efficacy and Safety of DEXTENZA in Pseudo Phakic Patients Undergoing Gas Bubble Repair and Laser Following Retinal Detachment". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04464629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*